Login / Signup

Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients.

Jan W TraubHannah L PellkoferKatja GrondeyIra SeegerChristoph RowoldWolfgang BrückLeila HusseiniSilke Häusser-KinzelMartin S Weber
Published in: Journal of neuroinflammation (2019)
Protocols were approved by the ethical review committee of the University Medical Center Göttingen (#3/4/14).
Keyphrases
  • multiple sclerosis
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • white matter
  • decision making